Screener
Bristol-Myers Squibb BMY Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Bristol-Myers Squibb’s reported figures.
The source filing: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 11:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000014272-26-000020
FAQ
- What is Bristol-Myers Squibb's free cash flow?
- Bristol-Myers Squibb (BMY) reported free cash flow of $3.09B in Q2 2026.
- How has Bristol-Myers Squibb's free cash flow changed year-over-year?
- Bristol-Myers Squibb's free cash flow decreased by 13.2% year-over-year, from $3.56B to $3.09B.
- What is the long-term trend for Bristol-Myers Squibb's free cash flow?
- Over 4 years (2021 to 2025), Bristol-Myers Squibb's free cash flow has grown at a -4.2% compound annual growth rate (CAGR), from $15.23B to $12.85B.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Bristol-Myers Squibb's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude